Aggressive Relapsed or Refractory B-cell Non-hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2020-12-04
  Clinical Trial Update: Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden [Phase 1, Phase 2]

  Early-phase clinical trial investigating decitabine-primed tandem CD19/CD20 CAR T cells combined with epigenetic agents for aggressive relap…